CFDB - Cystic Fibrosis DataBase

All subcategories » congress abstract

Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Who Previously Discontinued Lumacaftor/Ivacaftor Due To Respiratory Adverse Events: a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

primary studies  congress abstract

Details
  • 2019
  • Schwarz C

Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis

primary studies  congress abstract

Details
  • 2019
  • Singh S

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)

primary studies  congress abstract

Details
  • 2019
  • Sommerburg O

Alternative therapies in patients with cystic fibrosis who carry minimal residual function mutations

primary studies  congress abstract

Details
  • 2019
  • Tosco A

Is telehealth as effective as face to face therapy for delivery of whole body vibration training (WBVT) as an adjunct to physiotherapy in children and young people with cystic fibrosis (CF)?

primary studies  congress abstract

Details
  • 2019
  • Alexander E

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

primary studies  congress abstract

Details
  • 2019
  • Bell SC

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study

primary studies  congress abstract

Details
  • 2019
  • Dolce D

Stability of serum precipitins to Aspergillus fumigatus for the diagnosis of allergic bronchopulmonary aspergillosis

primary studies  congress abstract

Details
  • 2019
  • Lau KSK

Inhaled dry powder alginate oligosaccharide (OligoG) in cystic fibrosis: sub-group analyses of a double-blind, randomized, placebo-controlled, efficacy and safety trial

primary studies  congress abstract

Details
  • 2019
  • Rye P

A prospective mixed-methods pilot study assessing the effects of improving diabetes education in adults with cystic fibrosis (IDEA-CF)

primary studies  congress abstract

Details
  • 2019
  • Sunsoa HK